•
OC
OCUL
Ocular Therapeutix, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
2.43B
Volume
217.57K
52W High
$16.44
52W Low
$5.79
Open
$0.00
Prev Close
$11.42
Day Range
0.00 - 0.00
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Latest News
Ocular Therapeutix Shares Surge Following Reports Of Stronger Sanofi Bid
Benzinga•Jan 15
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Dec 5
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Nov 7
OCUL Sales Drop 18%
The Motley Fool•Aug 6
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
GlobeNewswire Inc.•Jun 16
Ocular Therapeutix™ to Participate in Two Investor Conferences in April
GlobeNewswire Inc.•Mar 31
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Jan 17
Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings)
Benzinga•Jun 14